The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II LAPACT trial of nab-paclitaxel (nab-P) plus gemcitabine (G) for patients with locally advanced pancreatic cancer (LAPC).
 
Pascal Hammel
Honoraria - Celgene
Consulting or Advisory Role - Celgene; Shire
Speakers' Bureau - Celgene
Travel, Accommodations, Expenses - Ipsen; Merck Serono
 
Jill Lacy
Consulting or Advisory Role - Celgene; LEK; Sirtex Medical
Travel, Accommodations, Expenses - Lilly
 
Fabienne Portales
Honoraria - Sanofi
Travel, Accommodations, Expenses - Roche
 
Alberto F. Sobrero
Consulting or Advisory Role - Amgen; Bayer; Celgene; Merck Serono; Roche; Sanofi; SERVIER
Speakers' Bureau - amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; celgene; Lilly; Merck Serono; Roche; Sanofi; Takeda
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche
 
Roberto A. Pazo Cid
No Relationships to Disclose
 
Jose Luis Manzano Mozo
No Relationships to Disclose
 
Eric Terrebonne
No Relationships to Disclose
 
Scot D. Dowden
Honoraria - Celgene; Lilly; Roche Canada; Sanofi
Consulting or Advisory Role - Celgene; Lilly; Roche Canada; Sanofi
Speakers' Bureau - Amgen; Celgene; Roche Canada
 
Jack Shiansong Li
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Teng Jin Ong
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Thom Nydam
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Philip Agop Philip
Honoraria - Amgen; Bayer; Bristol-Myers Squibb; Celgene; Halozyme; Ipsen; Merrimack; Novartis; Roche; Sanofi
Consulting or Advisory Role - Celgene; Gilead Sciences; Halozyme; Ipsen; Merrimack; novartis
Speakers' Bureau - amgen; Bayer; Celgene; roche; sanofi
Research Funding - Bayer (Inst); Genentech (Inst); Immunomedics (Inst); incyte (Inst); Karyopharm Therapeutics (Inst); Merck (Inst); Momenta Pharmaceuticals (Inst); novartis (Inst); Plexxikon (Inst); Regeneron (Inst); Taiho Pharmaceutical (Inst)
Other Relationship - Celgene; emd serono; Halozyme; Roche; sanofi